Pushkar Pharma

Reading time: 8 minutes | Last updated: June 2026 Author: Pushkar Pharma — WHO-GMP Certified Eye Drop Manufacturer, Kala Amb, Himachal Pradesh If you are a pharma entrepreneur, PCD franchise owner, or marketing company looking to launch eye drops in India, you have likely come across two terms — third party manufacturing and contract manufacturing . Most businesses use them interchangeably. That is a costly mistake. The model you choose directly affects your production cost, brand ownership, regulatory liability, launch speed, and long-term scalability. Choosing the wrong one — especially in the ophthalmic segment — can delay your market entry by months and create compliance gaps you may not discover until an audit. This guide breaks down both models specifically for eye drop manufacturing in India , explains what separates them in practice, and helps you decide which one fits your business right now. What Is Third-Party Eye Drop Manufacturing? Third-party manufacturing (also call...

About Pushkar Pharma Pushkar Pharma is a trusted pharmaceutical manufacturing company specializing in eye drops, ENT products, ophthalmic manufacturing, sterile injectables, and third party pharma manufacturing services in India. This page is created to organize all official backlinks, profile links, social references, podcast profiles, article submissions, infographic links, and business citations associated with Pushkar Pharma. Search engines regularly crawl active backlink reference pages containing categorized authority links. Organizing backlinks in one place can improve crawl frequency, backlink discovery, indexing signals, and digital visibility for pharmaceutical manufacturing related searches. Podcast Profiles & Audio Platforms Injectable & Ophthalmic Podcast Profiles https://www.spreaker.com/podcast/injectable-ophthalmic-insights--7063419 https://open.spotify.com/show/033or8Qd9YfO2d0sytkujX https://podcastaddict.com/podcast/injectable-ophthalmic-insights/7049467 http...

  The demand for eyedrop manufacturing in India is increasing steadily in 2026 because eye-related problems are becoming more common due to lifestyle changes, long screen exposure, pollution, and aging-related conditions.  Recent studies show that around 37% of people in urban India suffer from dry eye disease , and prolonged screen time above 4 hours per day significantly increases the risk of dry eye symptoms . In urban clinics, doctors also report a continuous rise in cases, with 15–20 patients every week showing dry eye symptoms , especially among working professionals and students. As more people face issues like dry eyes, infections, and glaucoma, the need for safe and sterile eye drop products is also rising.  This growing health need is directly pushing pharmaceutical brands to depend more on reliable eye drop manufacturers in India.  Key Factors Behind This Growth India’s eyedrop market is valued at around USD 219.9 million in 2025 and is expected to reach ...